NCT00069719

Brief Summary

To determine the safety and IOP-lowering ability of a test compound in patients with open-angle glaucoma or ocular hypertension.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Timeline
Completed

Started Feb 1999

Typical duration for phase_2

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 1999

Completed
4.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2003

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2003

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

September 30, 2003

Completed
6 days until next milestone

First Posted

Study publicly available on registry

October 6, 2003

Completed
Last Updated

August 5, 2008

Status Verified

August 1, 2008

Enrollment Period

4.5 years

First QC Date

September 30, 2003

Last Update Submit

August 4, 2008

Conditions

Open-Angle GlaucomaOcular Hypertension

Keywords

open-angleglaucomaocularhypertensionPOAG

Interventions

Glaucoma therapyDRUG

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult subjects of either sex and any race with open-angle glaucoma or ocular hypertension;
  • logMAR visual acuity not worse than 0.6.

You may not qualify if:

  • Clinically relevant ophthalmic or systemic conditions may be excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Alcon Clinical Trial Sites

Multiple Locations Throughout the US Sponsored by Alcon of, Texas, United States

Location

MeSH Terms

Conditions

Glaucoma, Open-AngleOcular HypertensionGlaucomaHypertension

Condition Hierarchy (Ancestors)

Eye DiseasesVascular DiseasesCardiovascular Diseases

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
DOUBLE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY

Study Record Dates

First Submitted

September 30, 2003

First Posted

October 6, 2003

Study Start

February 1, 1999

Primary Completion

August 1, 2003

Study Completion

August 1, 2003

Last Updated

August 5, 2008

Record last verified: 2008-08

Locations

US(1)